IP Verse

Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab

Patent No. EP4234033 (titled "Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab") was filed by F Hoffmann LA Roche on Oct 11, 2012. The application was issued on Jan 29, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ABEL & IMRAYOct 29, 2025ABEL & IMRAY
STORZOct 29, 2025-
J A KEMPOct 28, 2025J A KEMP
LANYON OPPOSITIONSOct 28, 2025PINSENT MASONS
BRAND MURRAY FULLEROct 23, 2025BRAND MURRAY FULLER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4234033

F HOFFMANN LA ROCHE
Application Number
EP23172794A
Filing Date
Oct 11, 2012
Status
Granted And Under Opposition
Dec 26, 2024
Publication Date
Jan 29, 2025
External Links
Slate, Register , Google Patents